Ion channel blockers and glioblastoma risk and outcome: a nested case–control and retrospective cohort studies

Mutations in ion channels are common among patients with glioblastoma multiforme (GBM) and promote cell migration and invasion. We sought to evaluate the association between the use of specific ion channel blockers such as digoxin, amiodarone, diltiazem and verapamil and GBM risk and survival.

[1]  M. Jadus,et al.  Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy. , 2014, International immunopharmacology.

[2]  S. Yu,et al.  Inhibition of Na+/K+-ATPase induces hybrid cell death and enhanced sensitivity to chemotherapy in human glioblastoma cells , 2014, BMC Cancer.

[3]  S. Robert,et al.  A proinvasive role for the Ca2+‐activated K+ channel KCa3.1 in malignant glioma , 2014, Glia.

[4]  H. Katus,et al.  Herg K+ Channel-Dependent Apoptosis and Cell Cycle Arrest in Human Glioblastoma Cells , 2014, PloS one.

[5]  C. Limatola,et al.  KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo , 2013, Cell Death and Disease.

[6]  R. Puca,et al.  The Inhibition of KCa3.1 Channels Activity Reduces Cell Motility in Glioblastoma Derived Cancer Stem Cells , 2012, PloS one.

[7]  A. Levchenko,et al.  Regulation of Brain Tumor Dispersal by NKCC1 Through a Novel Role in Focal Adhesion Regulation , 2012, PLoS biology.

[8]  B. O'neill,et al.  Glioblastoma survival in the United States before and during the temozolomide era , 2012, Journal of Neuro-Oncology.

[9]  S. Leenstra,et al.  Recent advances in the molecular understanding of glioblastoma , 2009 .

[10]  D. Benos,et al.  Glioma-specific Cation Conductance Regulates Migration and Cell Cycle Progression* , 2011, The Journal of Biological Chemistry.

[11]  Helena Borges,et al.  Glioblastoma cells: a heterogeneous and fatal tumor interacting with the parenchyma. , 2011, Life sciences.

[12]  A. Bourke,et al.  Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. , 2011, Informatics in primary care.

[13]  T. Kwon,et al.  Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. , 2011, Neuro-oncology.

[14]  V. Velculescu,et al.  Sodium ion channel mutations in glioblastoma patients correlate with shorter survival , 2011, Molecular Cancer.

[15]  G. Leung,et al.  Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3. , 2010, Anticancer research.

[16]  A. A. Mongin,et al.  Calcium-Activated Potassium Channels BK and IK1 Are Functionally Expressed in Human Gliomas but Do Not Regulate Cell Proliferation , 2010, PloS one.

[17]  H. Sontheimer,et al.  Inhibition of the Sodium-Potassium-Chloride Cotransporter Isoform-1 reduces glioma invasion. , 2010, Cancer research.

[18]  H. Sontheimer,et al.  Molecular Interaction and Functional Regulation of ClC-3 by Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) in Human Malignant Glioma* , 2010, The Journal of Biological Chemistry.

[19]  Kevin Haynes,et al.  Cancer incidence in The Health Improvement Network , 2009, Pharmacoepidemiology and drug safety.

[20]  G. Hall.  Validation of death and suicide recording on the THIN UK primary care database , 2009, Pharmacoepidemiology and drug safety.

[21]  H. Sontheimer,et al.  ClC3 Is a Critical Regulator of the Cell Cycle in Normal and Malignant Glial Cells , 2008, The Journal of Neuroscience.

[22]  T. Mikkelsen,et al.  Genomic Changes and Gene Expression Profiles Reveal That Established Glioma Cell Lines Are Poorly Representative of Primary Human Gliomas , 2008, Molecular Cancer Research.

[23]  H. Sontheimer,et al.  Role of Kir4.1 channels in growth control of glia , 2007, Glia.

[24]  D. Benos,et al.  Participation of the Chaperone Hsc70 in the Trafficking and Functional Expression of ASIC2 in Glioma Cells* , 2007, Journal of Biological Chemistry.

[25]  W. Bilker,et al.  Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research , 2007, Pharmacoepidemiology and drug safety.

[26]  Margaret Wrensch,et al.  Epidemiology and molecular pathology of glioma , 2006, Nature Clinical Practice Neurology.

[27]  H. Sontheimer,et al.  Expression and function of calcium‐activated potassium channels in human glioma cells , 2006, Glia.

[28]  D. Benos,et al.  Surface Expression of ASIC2 Inhibits the Amiloride-sensitive Current and Migration of Glioma Cells* , 2006, Journal of Biological Chemistry.

[29]  N. Di Lorenzo,et al.  hERG1 channels are overexpressed in glioblastoma multiforme and modulate VEGF secretion in glioblastoma cell lines , 2005, British Journal of Cancer.

[30]  W. Bilker,et al.  The relationship between time since registration and measured incidence rates in the General Practice Research Database , 2005, Pharmacoepidemiology and drug safety.

[31]  A. Bourke,et al.  Feasibility study and methodology to create a quality-evaluated database of primary care data. , 2004, Informatics in primary care.

[32]  H. Sontheimer,et al.  Role for calcium‐activated potassium channels (BK) in growth control of human malignant glioma cells , 2004, Journal of neuroscience research.

[33]  H. Sontheimer,et al.  Mislocalization of Kir channels in malignant glia , 2004, Glia.

[34]  H. Sontheimer,et al.  Expression of Voltage-Gated Chloride Channels in Human Glioma Cells , 2003, The Journal of Neuroscience.

[35]  C. B. Ransom,et al.  BK channels in human glioma cells have enhanced calcium sensitivity , 2002, Glia.

[36]  Harald Sontheimer,et al.  Cloning and Characterization of Glioma BK, a Novel BK Channel Isoform Highly Expressed in Human Glioma Cells , 2002, The Journal of Neuroscience.

[37]  R. Jensen,et al.  Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice. , 2001, Surgical neurology.

[38]  C. B. Ransom,et al.  BK channels in human glioma cells. , 2001, Journal of neurophysiology.

[39]  L. Soroceanu,et al.  Modulation of Glioma Cell Migration and Invasion Using Cl− and K+ Ion Channel Blockers , 1999, The Journal of Neuroscience.

[40]  D. Benos,et al.  Malignant human gliomas express an amiloride-sensitive Na+ conductance. , 1999, American journal of physiology. Cell physiology.

[41]  J H Lubin,et al.  Biased selection of controls for case-control analyses of cohort studies. , 1984, Biometrics.

[42]  Y. Lee,et al.  In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists. , 1995, Neurosurgery.

[43]  B. W. Lichtenstein,et al.  Neoplasms in the nervous system. , 1949 .